Fortune magazine has a revealing look at a growing uneasiness with free trade among America’s middle class. Washington Editor Nina Easton in her article, “America Sours on Free Trade,” cites a new Fortune survey that found 78 percent of those surveyed feel that free trade has made life worse for American workers.
Archive for January, 2008
January28
Fortune weighs in on free trade
January25
Media roundup
- ABC News: Consumer group calls for stronger warnings on Botox
- NY Times: Group seeks new Botox warning
- Houston Chronicle: Feds propose new vehicle roof rule
- FOXBusiness: As infomercials move to mainstream TV, stay alert for scams
- Voice of America: Pfizer fights Nigerian lawsuits
January25
Presidential candidates talk about trade
From Holly Shulman @ Eyes on Trade: Maybe this sounds like a bad joke, but what do Austan Goolsbee, Barack Obama’s economic advisor, Gary Gensler (Clinton campaign) Kevin Hassett (McCain) and Leo Hindery (Edwards) have in common? (hint: it’s not exhaustion from the campaign trail or a common love for walks on the beach…as far as I know)
January24
Botoxic?
Frankly, we’d be worried if anyone told us they were going to inject botulinum toxin – the same toxin that causes food poisioning – into our body. However, that doesn’t stop many people from choosing Botox and Myobloc for therapeutic, as well as purely cosmetic reasons. What many of these people don’t know is that those injections could kill them.
Public Citizen has petitioned the Food and Drug Administration to immediately ramp up its warnings to doctors and patients about the risk of the toxin spreading to other parts of the body — with serious, sometimes fatal, consequences.
January23
Still more on the Vytorin, Zetia fallout
As the Vytorin-Zetia story continues to pick up traction in the mainstream media and on the Web, it looks like the drug makers, Merck and Schering-Plough, are in full damage-control mode. In what’s probably a smart move, the AP reports the pharma companies pulled their highly successful ads for Vytorin. Merck and Schering-Plough also bought a TWO page ad in Wednesday’s Wall Street Journal that stood by Vytorin’s cholesterol-reducing ability.
